
|Articles|February 10, 2017
Declining Hepatitis C Drug Costs Highlights Specialty Pharmacy Week in Review
Author(s)Davy James, Managing Editor
Top articles of the week on Specialty Pharmacy Times.
Advertisement
[<a href="//storify.com/pharmacytimes/declining-hepatitis-c-drug-costs-highlights-specia" target="_blank">View the story "Declining Hepatitis C Drug Costs Highlights Specialty Pharmacy Week in Review" on Storify</a>]
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Five-Year NATALEE Data Show Ribociclib Improves Outcomes in High-Risk HR+/HER2– Early Breast Cancer
2
Abemaciclib Provides Long-Term Survival Benefit in High-Risk Early Breast Cancer
3
Cholesterol-HDL-Glucose Index Linked to Type 2 Diabetes Prevalence in Adults
4
Under Pressure: A Brief Overview of the Updated Hypertension Guidelines
5